Ratio of neutrophils to lymphocytes and apoptosis of lymphocytes in patients with HBV and HCV depending on the stage of liver fibrosis
https://doi.org/10.25789/YMJ.2024.86.20
Abstract
A common complication of HBV and HCV is liver cirrhosis, which is based on chronic systemic inflammation associated with immune dysfunction that affects the progression of the disease.
The purpose of the study. Determination of NLR and lymphocyte apoptosis index as a marker of the degree of inflammation and systemic immuno-inflammatory response in various degrees of liver fibrosis in patients with viral hepatitis.
Materials and methods. 107 patients underwent the study, of which 53 patients were diagnosed with HBV and 54 with HCV. The blood levels of leukocytes, neutrophils, and lymphocytes were studied in the studied patients and the neutrophil/lymphocyte ratio (NEU/LYM) was determined. In order to verify structural changes in the liver, ultrasound elastometric examination was performed on a 2D – Supersonic Aixplorer SWE device (France) for all persons with esTableished viral hepatitis. The examination of patients was carried out according to the Cut–off scale, and liver fibrosis was determined by the METAVIR scale. A group of 10 practically healthy individuals was selected as a comparison group. The values of the indicators were expressed in kPa, the value of the indicator 7.1 kPa corresponded to F2, 9.2 kPa – F3, F4≥13.5 kPa. Verification of HBV and HCV was carried out by PCR on the device “Rotor Qene Q” (Germa
The results obtained showed an increase in the absolute number of lymphocytes with a decrease in the NLR indicator against the background of a decrease in the apoptosis marker of CB95+ lymphocytes with varying degrees of liver fibrosis. A decrease in this marker reflects the damaging effect of hepatotropic viruses, which is indirectly confirmed by the detected leukocytosis.
About the Authors
N. A. Faradzheva
A. Aliyev Azerbaijan State Institute of Advanced Medical Education
Azerbaijan
Azerbaijan
Faradzheva Natavan Alysh kizi – Doctor of Medical Sciences, Professor, Department of Therapy
K. J. Mahmudova
Medikus Clinic' Medical Center
Azerbaijan
Azerbaijan
Mahmudova Konul Jahangir kizi – therapist.
Baku
L. M. Ahmedova
A. Aliyev Azerbaijan State Institute of Advanced Medical Education
Azerbaijan
Azerbaijan
Ahmadova Leyli Mamed kizi – PhD in Medicine, Senior Researcher at the Central Research Laboratory
References
1. Bueverov A.O., Mayevskaya M.V. Clinical significance of apoptosis in chronic viral hepatitis // Medical Bulletin of the North Caucasus. 2009. No.2. Р. 4-9. УДК 616.36–002.2:576.858:616.98
2. Kalyuzhin O.V., Ponezheva J.B., Semenova I.V., etc. Lymphocyte subpopulations, interferon levels and expression of their receptors in patients with chronic hepatitis B and C: dependence on the type of viruses and degree of liver fibrosis //Therapeutic Archive. 2017. No.11. Р.14-20. doi.org/10.17116/terarkh2017891114-20.
3. Lunkov V.D., Mayevskaya M.V., Tsvetaeva E.K., etc. The ratio of neutrophils to lymphocytes as a predictor of an unfavorable outcome in patients with decompensated cirrhosis of the liver //Ross. journal of Gastroenterology, Hepatology, 2019, 29(1); 47-61. doi.org/10.22416/1382-4376-2019-29-1-47-61.
4. Mannova I.V. Clinical and pathogenetic significance of the immune status in the formation of liver fibrosis in patients with chronic hepatitis C: Abstract of the dissertation, PhD. 2019. 24 p.
5. Sarkarova M.R., Mayevskaya M.V. Prognostic and diagnostic significance of the ratio of neutrophils to lymphocytes in patients with diseases of the gastrointestinal tract and liver // Medical advice, 2022;16(7):60-68. doi.org/10.21518/2079-701X-2022-16-7-60-68.
6. Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance //J Hepatol., 2014;61:1385-1396. doi:10.1016/j.jhep.2014.08.010.
7. Asrani S.K, Devarbhavi H., Eaton J., Kamath P.S. Burden of liver diseases in the world // J Hepatol. 2019;70(1):151-71. https://doi.org/10.1016/j.jhep.2018.09.014.
8. Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acuteon-chronic liver failure //Medicine (Baltimore) 2018; 97 :e13324. doi: 10.1097/MD.0000000000013324.
9. Chiriac S., Stanciu C., Singeap AM, Sfarti C.V. et al. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acuteon-chronic liver failure // Turk J Gastroenterol., 2020; 31(12): 868–876. doi: 10.5152/tjg.2020.19838.
10. Hashemi S.J., Tosi M.S., Hajiani E. et. al., The Association Between Peripheral Blood Neutrophil-to-Lymphocyte Ratio and Cirrhosis Complications in Adults with Compensated Liver Cirrhosis in Ahvaz, Iran //Shiraz E-Med J.,2023;24(8):e138859. doi.org/10.5812/semj-138859.
11. Jia-Rui Zheng, Zi-Long Wang, Bo Feng. Hepatitis B functional cure and immune response //Front Immunol. 2022; Nov 17:13:1075916. doi:10.3389/fimmu.2022.1075916.
12. Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis // BMC Gastroenterol. 2015;15:146.
13. Moreau R., Jalan R., Gines P. et al. Acuteon-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis // Gastroenterology, 2013;144:1426–37. doi:10.1053/j.gastro.2013.02.042.
14. Noor MT, Manoria P. Immune Dysfunction in Cirrhosis //J Clin Transl Hepatol., 2017;5:50-58. doi: 10.14218/JCTH.2016.00056.
15. Peng Y., Li Y., He Y. et. al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review // Expert Rev Gastroenterol Hepatol., 2018;12 (5):503–513. https://doi.org/10.1080/17474124.2018.1463158
16. Štimac D., Nardone G., Mazzari A., et al. What’s New in Diagnosing Diverticular Disease // Journal of Gastrointestinal and Liver Diseases. - 2019, Dec19. 28 (4). р. 17-22. doi: 10.15403/jgld-553.
17. World Health Organization. Hepatitis В (2022). Available at: https://www.who.int/newsroom/fact-sheets/detail/hepatitis-b (Accessed October 21, 2022).
18. Xue TC, Zhang L, Xie XY, Ge NL, Li LX, Zhang BH, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: A meta-analysis //PLoS One. 2014;9(5). e96072. https://doi.org/10.1371/journal.pone.0096072.
19. Zhang J, Feng G, Zhao Y, Zhang J, Feng L, Yang J. Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study // BMJ Open, 2015; 5: e008033. doi: 10.1136/bmjopen-2015-008033.
20. Zhang W., Aryan M., Chen Z. et. al. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt // Eur J Gastroenterol Hepatol. 2022 Apr 1;34(4):435-442. doi: 10.1097/MEG.0000000000002295.
Review
For citations:
Faradzheva N.A., Mahmudova K.J., Ahmedova L.M. Ratio of neutrophils to lymphocytes and apoptosis of lymphocytes in patients with HBV and HCV depending on the stage of liver fibrosis. Yakut Medical Journal. 2024;(2):84-87. https://doi.org/10.25789/YMJ.2024.86.20
Views:
64
Email this article 